Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.
AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.
AROA CEO,
View original content:https://www.prnewswire.com/news-releases/aroa-biosurgery-limited-announces-the-recent-appointments-of-michael-lynskey-and-mike-falcon-to-its-us-based-commercial-team-302835995.html
SOURCE Aroa Biosurgery
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- fileAI Signs Strategic Collaboration Agreement with AWS to Accelerate Rollout of Outcome-Driven AI Agents for BFSI Leaders
- Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity
- Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share